Key facts
- This page summarizes John E. Davis's Form 4 filing for CRYOLIFE INC (AORT).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 May 2021, 17:02.
John E. Davis - 25 May 2021 Form 4 Insider Report for CRYOLIFE INC (AORT)
- Reporting relationship
- Senior VP, Global Sales
- Issuer ticker
- AORT
- Reported as of
- 25 May 2021
- Net transaction value
- -$377,880
- SEC form
- 4
- Accepted by SEC
- 27 May 2021, 17:02:28 UTC
- Next SEC filing
- 01 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ John E Davis
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John E. Davis filed Form 4 for CRYOLIFE INC (AORT) on 27 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$377,880.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AORT
transaction
Common Stock
Sale
- Transaction value
- $160,275
- Shares
- -5,402
- Change %
- -6.4%
- Price
- $29.67
- Shares after
- 79,236
- Date
- 25 May 2021
- Ownership
- Direct
- Footnotes
- F1
AORT
transaction
Common Stock
Sale
- Transaction value
- $26,135
- Shares
- -880
- Change %
- -1.1%
- Price
- $29.70
- Shares after
- 78,356
- Date
- 25 May 2021
- Ownership
- Direct
- Footnotes
- F2
AORT
transaction
Common Stock
Sale
- Transaction value
- $191,470
- Shares
- -6,457
- Change %
- -8.2%
- Price
- $29.65
- Shares after
- 71,899
- Date
- 25 May 2021
- Ownership
- Direct
- Footnotes
- F3
AORT
transaction
Common Stock
Options Exercise
- Transaction value
- $141,748
- Shares
- +5,402
- Change %
- +6.8%
- Price
- $26.24
- Shares after
- 84,638
- Date
- 25 May 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AORT
transaction
Derivative
Stock Options (Right To buy)
Options Exercise
- Transaction value
- $141,748
- Shares
- -5,402
- Change %
- -100%
- Price
- $26.24
- Shares after
- 0
- Date
- 25 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,402
- Exercise price
- $26.24
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Reflects weighted average price. Range of prices were between $29.47 to $30.14. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F2
Reflects weighted average price. Range of prices were between $29.47 to $30.04. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
Reflects weighted average price. Range of prices were between $29.44 to $30.135. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F4
Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2021